- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03787147
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI) (VR adult)
January 12, 2021 updated by: Sayed Wahezi, Albert Einstein College of Medicine
A three-group parallel randomized controlled trial to evaluate the efficacy of virtual reality analgesia (VRA) to decrease patient procedural pain and anxiety in the Adult patients undergoing Spinal Injections (SI).
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 2
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult requiring Spinal Injections
- Adult > 18years
- Adults with intact vision who can attend VR intervention
Exclusion Criteria:
- Anyone < 18 years
- Adults who are not attentive to VR secondary to poor concentration, poor cognition to external stimuli
- Adults who request moderate IV sedation
- Adults with photic-induced seizures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Spinal Injection
Adults receiving Spinal Injection(SI) without Virtual Reality(VR).
|
All groups will receive pharmaceutical analgesia, either lidocaine or bupivacaine, depending on the condition.
Dosage and frequency of pharmaceutical analgesia will be tailored to each participant's condition.
All groups will receive pharmaceutical analgesia, either lidocaine or bupivacaine, depending on the condition.
Dosage and frequency of pharmaceutical analgesia will be tailored to each participant's condition.
|
Active Comparator: Google Cardboard
Adults receiving SI while using Google Cardboard Virtual reality head mounted display powered by a iPod touch
|
All groups will receive pharmaceutical analgesia, either lidocaine or bupivacaine, depending on the condition.
Dosage and frequency of pharmaceutical analgesia will be tailored to each participant's condition.
All groups will receive pharmaceutical analgesia, either lidocaine or bupivacaine, depending on the condition.
Dosage and frequency of pharmaceutical analgesia will be tailored to each participant's condition.
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI).
VRA is a the oculus or the google cardboard that helps decrease anxiety.
The participant in the oculus or the Google cardboard arms are asked to watch VR videos during the spinal injection.
|
Active Comparator: Oculus
Adults receiving SI while using VR with Oculus Rift.
|
All groups will receive pharmaceutical analgesia, either lidocaine or bupivacaine, depending on the condition.
Dosage and frequency of pharmaceutical analgesia will be tailored to each participant's condition.
All groups will receive pharmaceutical analgesia, either lidocaine or bupivacaine, depending on the condition.
Dosage and frequency of pharmaceutical analgesia will be tailored to each participant's condition.
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI).
VRA is a the oculus or the google cardboard that helps decrease anxiety.
The participant in the oculus or the Google cardboard arms are asked to watch VR videos during the spinal injection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity as measured by the Visual Analog Scale
Time Frame: Immediately after receiving spinal injection
|
Participants are asked to rate their intensity of pain, by completing a Visual Analog Scale (VAS).
The VAS consists of lines and emojis used to indicate pain level; the lines range from 0 (= no pain) to 10 (= unbearable pain) and the emojis range from 0 (= no pain) to 5 (= unbearable pain).
|
Immediately after receiving spinal injection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety Level as measured by the Visual Facial Anxiety Scale
Time Frame: Immediately after receiving spinal injection
|
Participants are asked to rate their anxiety level by completing the Visual Facial Anxiety Scale(VFAS).
The VFAS consists of emojis ranging from 0 (= no anxiety) to 5 (highest anxiety).
|
Immediately after receiving spinal injection
|
Heart rate as measured by the Empatica E4 wristband
Time Frame: Baseline, during and Immediately after the procedure
|
The Empatica E4 wristband is a wearable research device that offers real-time physiological data acquisition and software for in-depth analysis and visualization.
Empatica E4 wristband is worn by the participant throughout the procedure to measure heart rate before, during and after the procedure.
|
Baseline, during and Immediately after the procedure
|
Systolic Blood Pressure as measured by the Empatica E4 wristband
Time Frame: Baseline, during and Immediately after the procedure
|
The Empatica E4 wristband is a wearable research device that offers real-time physiological data acquisition and software for in-depth analysis and visualization.
Empatica E4 wristband is worn by the participant throughout the procedure to measure Blood Pressure before, during and after the procedure.
|
Baseline, during and Immediately after the procedure
|
Diastolic Blood Pressure as measured by the Empatica E4 wristband
Time Frame: Baseline, during and Immediately after the procedure
|
The Empatica E4 wristband is a wearable research device that offers real-time physiological data acquisition and software for in-depth analysis and visualization.
Empatica E4 wristband is worn by the participant throughout the procedure to measure Blood Pressure before, during and after the procedure.
|
Baseline, during and Immediately after the procedure
|
Sympathetic skin response as measured by the Empatica E4 wristband
Time Frame: Baseline, during and Immediately after the procedure
|
The Empatica E4 wristband is a wearable research device that offers real-time physiological data acquisition and software for in-depth analysis and visualization.
Empatica E4 wristband is worn by the participant throughout the procedure to measure Sympathetic skin response before, during and after the procedure.
|
Baseline, during and Immediately after the procedure
|
Temperature as measured by the Empatica E4 wristband
Time Frame: Baseline, during and Immediately after the procedure
|
The Empatica E4 wristband is a wearable research device that offers real-time physiological data acquisition and software for in-depth analysis and visualization.
Empatica E4 wristband is worn by the participant throughout the procedure to measure Temperature before, during and after the procedure.
|
Baseline, during and Immediately after the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sayed Wahezi, MD, Albert Einstein College Of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 30, 2020
Primary Completion (Anticipated)
December 1, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
December 5, 2018
First Submitted That Met QC Criteria
December 21, 2018
First Posted (Actual)
December 26, 2018
Study Record Updates
Last Update Posted (Actual)
January 14, 2021
Last Update Submitted That Met QC Criteria
January 12, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
- Bupivacaine
Other Study ID Numbers
- 2018-9613
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland
Clinical Trials on Lidocaine Hydrochloride
-
Rajmonda Nallbani-KomoniUnknownAnalgesic Drug DependenceKosovo
-
Lahey ClinicWithdrawn
-
Gil YosipovitchTerminated
-
Hospital de BaseCompleted
-
Tianjin Medical University General HospitalCompleted
-
Carilion ClinicWithdrawn
-
Zeng ChanghaoRecruiting
-
The Catholic University of KoreaWithdrawnthe Effect of Dexmedetomidine and Licodaine on Acute Postoperative Pain in Gynecological LaparoscopyGynecologic DiseaseKorea, Republic of
-
University Health Network, TorontoCompletedUterine LeiomyomasCanada
-
Jinling Hospital, ChinaCompleted